Insider Transactions in Q1 2023 at Inhibrx, Inc. (INBX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.96%
|
$960,000
$24.46 P/Share
|
|
Feb 28
2023
|
Mark Lappe Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
60
-0.0%
|
$1,500
$25.02 P/Share
|
|
Feb 02
2023
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
11,250
-0.27%
|
$281,250
$25.65 P/Share
|
|
Feb 01
2023
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
28,750
-0.45%
|
$718,750
$25.01 P/Share
|
|
Jan 24
2023
|
Mark Lappe Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,335
-0.09%
|
$108,375
$25.91 P/Share
|
|
Jan 23
2023
|
Mark Lappe Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
21,665
-0.86%
|
$541,625
$25.36 P/Share
|
|
Jan 23
2023
|
Jon Faiz Kayyem Director |
SELL
Open market or private sale
|
Indirect |
9,500
-0.29%
|
$237,500
$25.26 P/Share
|
|
Jan 04
2023
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
7,105
-0.17%
|
$163,415
$23.55 P/Share
|
|
Jan 03
2023
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
32,895
-0.51%
|
$789,480
$24.29 P/Share
|